Allianz’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.66M Buy
22,403
+8,546
+62% +$3.17M 0.09% 137
2026
Q1
$4.06M Sell
13,857
-1,678
-11% -$551K 0.05% 202
2025
Q4
$5.45M Buy
15,535
+1,678
+12% +$567K 0.07% 152
2025
Q3
$4.48M Buy
13,857
+19
+0.1% +$5.91K 0.1% 145
2025
Q2
$5.38M Sell
13,838
-19
-0.1% -$7.64K 0.13% 131
2025
Q1
$6.03M Sell
13,857
-620
-4% -$249K 0.16% 124
2024
Q4
$5.34M Sell
14,477
-1,782
-11% -$746K 0.14% 124
2024
Q3
$8.45M Buy
16,259
+1,801
+12% +$962K 0.23% 97
2024
Q2
$7.83M Sell
14,458
-1,387
-9% -$733K 0.23% 97
2024
Q1
$8.22M Buy
+15,845
New +$7.88M 0.26% 97

Other funds holding ELV

Allianz's ELV Position: Q2 2026 in Review

Allianz increased its Elevance Health (ELV) stake by 62% in Q2 2026, buying an estimated $3.17M and bringing the position to 22,403 shares worth $8.66M. The position accounts for 0.09% of the portfolio, ranked #137.

Allianz first reported a position in ELV in Q1 2024 and has held it in 10 quarters since. 1,604 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Allianz held 22,403 shares of Elevance Health worth $8.66M as of Q2 2026.
  • Allianz bought 8,546 Elevance Health shares in Q2 2026, an estimated $3.17M.
  • Elevance Health made up 0.09% of Allianz's portfolio in Q2 2026, its #137 holding.
  • Allianz first reported a position in Elevance Health in Q1 2024 and has held it in 10 quarters since.
  • 1,604 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.